EU-MEDICAL_DEVICES-ANX_I_7_8
EU-MEDICAL_DEVICES-ANX_I_7_8
Medical Devices Directive - Hazardous Substances
EU. Hazardous Substances for Purposes of Medical Devices Directive 93/42/EEC, 12 July 1993, amended by Directive 2007/47/EC, 21 September 2007
This list contains hazardous substances in accordance with the Medical Devices Directive's (MDD) design and construction requirements pursuant to Annex I, Part II (7) & (8) (i.e., chemical, physical and biological properties; and infection and microbial contamination). Specifically, the non-exhaustive database is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Please note that Regulation (EU) 2017/745 on medical devices has repealed Directive 93/42/EEC and begun to apply from 26 May 2021. Nevertheless, Article 120 of the Regulation provides for a transitional period allowing medical devices, under specified conditions (e.g., placed on the market prior to 26 May 2021), to continue to comply with the Directive. In accordance with the fourth paragraph of Article 120, this period ends 26 May 2025.
Last updated 23 April 2024. Database contains 4753 unique substances/entries.
Filter the list
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
F Fungi |
|||
|
-
|
-
|
F Fungi |
|||
|
-
|
-
|
P Parasites |
|||
|
-
|
-
|
P Parasites |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
Resp. Sens. 1 |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
Acute Tox. 3; STOT RE 2 |
|||
|
show/hide
|
-
|
-
|
Acute Tox. 2; Acute Tox. 1; STOT RE 2 |
||
|
-
|
-
|
Carc. 1B; Skin Sens. 1 |
|||
|
-
|
-
|
F Fungi |
|||
|
-
|
-
|
P Parasites |
|||
|
-
|
-
|
P Parasites |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
F Fungi |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
Substance identity is confidential or pending assessment. If possible, following assessment the proper substance identifiers will be displayed.
|
-
|
-
|
STOT RE 2 |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
68583-16-4
|
B Bacteria and similar species |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
572-48-5
|
Acute Tox. 3 |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
F Fungi |
|||
|
-
|
-
|
F Fungi |
|||
|
-
|
-
|
P Parasites |
|||
|
-
|
-
|
P Parasites |
|||
|
-
|
-
|
P Parasites |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
1563-67-3
|
Acute Tox. 3 |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
74195-78-1
|
Carc. 1A; STOT RE 1; Resp. Sens. 1; Skin Sens. 1 |
|||
|
-
|
-
|
Acute Tox. 4 |
|||
|
-
|
63919-26-6
|
Acute Tox. 4 |
|||
|
-
|
-
|
P Parasites |
|||
|
-
|
19372-20-4
|
Carc. 1A; STOT RE 1; Resp. Sens. 1; Skin Sens. 1 |
|||